Thermo Fisher Scientific Baltics: Strategic Biotech Supply Chains and Bio-Surveillance

Thermo Fisher Scientific Baltics, UAB is a Lithuanian-based manufacturing subsidiary of global life-sciences giant Thermo Fisher Scientific. Established on the former site of the Fermentas biotech spin‑off, its Vilnius facility is a cornerstone of Europe’s biotechnology supply chain .

The company specializes in the development and production of molecular biology and analytical chemistry products – reagents, enzymes, master mixes and laboratory instruments – that serve research, diagnostics and industrial customers worldwide . With over 1,400 employees at its Lithuanian headquarters , Thermo Fisher Baltics contributes roughly 2–3% of Lithuania’s GDP , reflecting its scale.

This analysis answers: What is Thermo Fisher Baltics' core production of molecular biology and analytical chemistry products (reagents, enzymes, master mixes, instruments)? How does its Vilnius facility, built on the former Fermentas site, anchor Europe's biotechnology supply chain and bio-surveillance? What does its scale (over 1,400 employees and roughly 2-3% of Lithuania's GDP) imply for strategic dependencies? What capability gaps and dual-use potential define its strategic significance?